Valuation for Biosyent Inc (id:1299 RX)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 19.38 |
|
|
| Forward P/E | 20.77 |
|
|
| Price to sales | 3.99 |
|
|
| Price to book | 3.93 |
|
|
| Enterprise to revenue | 3.39 |
|
|
| Enterprise to ebitda | 13.38 |
|
|